Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CELU | Class A Common Stock | Options Exercise | $215K | +769K | +2126.42% | $0.28 | 805K | Aug 26, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CELU | Stock Option (Right to Buy) | Options Exercise | $0 | -769K | -100% | $0.00* | 0 | Aug 26, 2022 | Class A Common Stock | 769K | $0.28 | Direct | F2 |
Id | Content |
---|---|
F1 | These shares include 36,145 restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of (i) July 13, 2023, such date being the one-year anniversary of the date of grant, and (ii) the next annual stockholder meeting; in each case subject to the Reporting Person's continuous service with the Issuer through such date |
F2 | This option is fully vested and exercisable. |